September Is Sickle Cell Awareness Month. While many people are familiar with sickle cell anemia, sickle cell traits have also plagued our community. Sickle cell trait (SCT) is an inherited blood ...
(Reuters Health) – African Americans with sickle cell trait - generally thought to be benign, unlike sickle cell disease - may still be at increased risk of kidney disease, a new study suggests. Based ...
Sickle cell disease is a global public health issue. Individuals with sickle cell disease (SCD) have two genes that cause the production of sickle hemoglobin, and these patients can have severe pain ...
Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up The presence of sickle cell trait among African Americans may ...
A treatment about to be tested in California holds the promise of possibly curing a debilitating disease, that disproportionately affects the African American community, sickle cell disease.
Sickle cell anemia causes sickle-shaped cells to block blood flow to the lungs, leading to acute chest syndrome. Common treatment methods involve oxygen supplementation and pain management. Sickle ...
LOS ANGELES — Children with sickle cell anemia are vulnerable to serious infections and stroke, but many do not receive the preventive care that could help them stay healthier longer, according to a ...
Hoosiers from across the state will gather at the Indiana State Capitol on Monday, Feb. 2, to call attention to the urgent ...
Please provide your email address to receive an email when new articles are posted on . Patients with myeloid and monocytic leukemia are at increased risk for leukemia. Future prospective studies are ...
Even the name sounds horrible − sickle cell disease − conjuring up images of menacing hooks, only these hooks are slicing through the bloodstream of an estimated 100,000 Americans, mostly Black ...
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...
LOS ANGELES (KABC) -- It's been more than a month since the FDA approved two milestone gene-editing treatments for sickle cell disease, but lining up patients for these therapies will be a challenge ...